MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • MDS Virtual Congress 2021

    Preventing falls in Parkinson’s disease by re-educating reactive and planned foot placement accuracy through a multi-sensory approach. 3 cases.

    D. Schlosser, Z. Mari (Las Vegas, USA)

    Objective: To demonstrate a novel approach to preventing falls in Parkinson’s disease (PD) that improves anticipatory postural adjustments facilitating a more accurate moving base of…
  • MDS Virtual Congress 2021

    Caregiving in Parkinson’s Disease: An International Perspective

    E. Book, R. Dawson, A. Allen, L. Kapust, J. Mckenzie, M. Ueda, A. Yu (Vancouver, Canada)

    Objective: The objective of the focus group study was to gain insight into the role of informal and formal resources in supporting caregivers of people…
  • MDS Virtual Congress 2020

    Using mindfulness to improve self-awareness in Parkinson’s disease patients – preliminary results of a randomized controlled trial

    T. Buchwitz, F. Maier, A. Greuel, C. Eggers (Marburg, Germany)

    Objective: This clinical trial aims to investigate the effects and feasibility of a newly developed 8-week mindfulness intervention on self-awareness in Parkinson’s disease (PD) patients.…
  • MDS Virtual Congress 2020

    Cardiovascular Fitness, Plasma Biomarkers and Dopaminergic Denervation in Parkinson’s Disease

    J. Morley, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda (Philadelphia, PA, USA)

    Objective: To examine the relationship between cardiovascular (CV) fitness, plasma biomarkers associated with PD progression and/or exercise and dopaminergic denervation, measured by I-123-Ioflupane single photon…
  • MDS Virtual Congress 2020

    The Cognitive Training In Parkinson Study (COGTIPS), a randomized controlled trial

    T. van Balkom, H. Berendse, Y. v.d. Werf, J. Twisk, R. Hagen, T. Berk, O. v.d. Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: In this randomized controlled trial [1], our objective was to assess the effect of online home-based cognitive training on objective cognitive functioning and subjective…
  • MDS Virtual Congress 2020

    Non-pharmacological Treatment for Parkinson’s Disease Patients with Depression: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment

    J.N Chen, P.K He, Y.H Zhang, YY. Gao, Y.H Qiu, Y. Li, Q.X Zhang, L.M Wang, J.H Zhao, K. Nie, L.J Wang (Guangzhou, China)

    Objective: This meta-analysis aims to assess the effect of non-pharmacological treatments for depression in patients with PD. Background: Antidepressants are the mainstay of treatment for…
  • MDS Virtual Congress 2020

    Novel walker attachment for gait dysfunction in Parkinson’s disease: Case report

    C. Gill, P. Schmitt, J. Karl, L. Verhagen Metman (Chicago, IL, USA)

    Objective: To describe a patient with advanced PD who noted improved balance and fewer falls while using a novel belt attachment for his assistive device.…
  • MDS Virtual Congress 2020

    Improving person – centered healthcare pathway organization for people with Parkinson’s disease, using Article 51.

    S. Bayen, C. Moreau, N. Carrière, JP. Pruvo, M. Bayen, F. Richard, B. Dervaux, L. Defebvre, D. Devos (Lille, France)

    Objective: To optimize efficacy and efficiency of the healthcare pathway (HCPW) for people with Parkinson’s disease (PwPD), using the political framework Article 51. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Ceftriaxone improves motor function in a rat hemi-parkinsonian model: Potential to delay bilateral progression of motor deficits in Parkinson’s disease

    E. Kasanga, C. McElroy, M. Salvatore (Fort Worth, TX, USA)

    Objective: This study sought to evaluate the impact of ceftriaxone, as a potential repurposed drug, in ameliorating motor decline in a unilateral rat 6-hydroxydopamine (6-OHDA)…
  • MDS Virtual Congress 2020

    From trials to clinical practice: Lessons from a specialized allied health implementation program for Parkinson’s disease

    S. Darweesh, M. Eimers, M. van Galen, M. Munneke, B. Bloem (Nijmegen, Netherlands)

    Objective: To determine how the coverage of specialized allied health services for patients with Parkinson’s disease (PD) has developed in the Netherlands since the publication…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley